Semaglutide is a GLP-1 receptor agonist that may help regulate appetite and support weight management as part of a clinician-supervised program. Lttl providers may consider compounded semaglutide when clinically appropriate following a full medical evaluation. It is administered by injection on a schedule determined by your provider. Plans start at $129/mo.
⚠ The compounded semaglutide offered through Lttl is not the same as FDA-approved semaglutide products and has not been reviewed or approved by the FDA for safety, effectiveness, or quality. Prescription required following evaluation through Lttl’s provider network.
Comments
0 comments
Please sign in to leave a comment.